The budgetary impact of 5-HT3 receptor antagonists in the management of chemotherapy-induced emesis

This publication has 20 references indexed in Scilit:

• Incidence and duration of chemotherapy-induced nausea and vomiting in the outpatient oncology population.
  Journal of Clinical Oncology, 1989
• Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial
  Cancer, 1987
• Optimum Management of Nausea and Vomiting in Cancer Chemotherapy
  Drugs, 1987
• The Management of Chemotherapy-Induced Nausea and Vomiting
  Medical Clinics of North America, 1987
• Review: The Management of Nausea and Vomiting in Clinical Oncology
  The Lancet Healthy Longevity, 1987
• Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy.
  Journal of Clinical Oncology, 1985
• Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients
  Cancer, 1985
• Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting.
  BMJ, 1984
• Extrapyramidal Reactions with High-Dose Metoclopramide
  New England Journal of Medicine, 1983
• On the receiving end—patient perception of the side-effects of cancer chemotherapy
  European Journal of Cancer and Clinical Oncology, 1983